Suboptimal immune recovery during antiretroviral therapy with sustained HIV suppression in sub-Saharan Africa-Reference-Cited by-同舟云学术

Suboptimal immune recovery during antiretroviral therapy with sustained HIV suppression in sub-Saharan Africa

Published:2018-05-15 Issue:8 Volume:32 Page:1043-1051
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:

Author:

Kroeze Stefanie,Ondoa Pascale,Kityo Cissy M.,Siwale Margaret,Akanmu Sulaimon,Wellington Maureen,de Jager Marleen,Ive Prudence,Mandaliya Kishor,Stevens Wendy,Boender T. Sonia,de Pundert Marieke E.,Sigaloff Kim C.E.,Reiss Peter,Wit Ferdinand W.N.M.,Rinke de Wit Tobias F.,Hamers Raph L.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference55 articles.

1. Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study. Swiss HIV Cohort Study;Egger;BMJ,1997

2. Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration. Multicenter AIDS Cohort Study Investigators;Detels;JAMA,1998

3. Long-term virological outcomes of first-line antiretroviral therapy for HIV-1 in low- and middle-income countries: a systematic review and meta-analysis;Boender;Clin Infect Dis,2015

4. Immunological recovery and antiretroviral therapy in HIV-1 infection;Battegay;Lancet Infect Dis,2006

5. CD4+ T lymphocyte recovery in individuals with type 1 human immunodeficiency virus infection;Maggiolo;Clin Infect Dis,2010

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost-effectiveness of pretreatment HIV drug resistance testing in people living with HIV in Iran;PLOS ONE;2024-09-06

2. Development of an extended action fostemsavir lipid nanoparticle;Communications Biology;2024-07-30

3. Specific plasma microRNAs are associated with CD4+ T-cell recovery during suppressive antiretroviral therapy for HIV-1;AIDS;2024-02-01

4. Trends and the associated factors of optimal immunological response and virological response in late anti-retroviral therapy initiation HIV cases in Taiwan from 2009 to 2020;Journal of Infection and Public Health;2024-02

5. Enhanced Expression of Two ISGs as Potential Biomarkers of Prognosis in HIV-Infected Immunological Non-Responders;Zoonoses;2024